NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live AIM ImmunoTech Inc. Share Price Chart

O H L

AIM ImmunoTech Inc. Performance Overview

Days Range
$0.21Low
$0.21High

Markets Today

Previous Close$0.22
Open$0.21
Volume387,032
Day's Range$0.21 - $0.21
52W Range$0.19 - $2.88
Market Cap$8.31 M

Historical Performance

1M Returns-7.10
3M Returns-42.80
6M Returns-78.70
1Y Returns-91.67
5Y Returns-89.34
10Y ReturnsNA

AIM ImmunoTech Inc. Fundamentals

Market Cap$8.31 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$88.00 K
ROE TTMN/A
EPS TTM$-3.93
Quarterly Earnings Growth YOYN/A
PB Ratio0.79
EBITDA$-11.45 M
Profit Margin-15861.36
Market Cap$8.31 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$88.00 K
ROE TTMN/A
EPS TTM$-3.93
Quarterly Earnings Growth YOYN/A
PB Ratio0.79
EBITDA$-11.45 M
Profit Margin-15861.36

AIM ImmunoTech Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$16.00 K$25.00 K$26.00 K$21.00 K$22.00 K$26.00 K
Gross Profit +$6.00 K$15.00 K-$42.00 K-$19.00 K$18.00 K$21.00 K
Operating Income -$3.62 M-$2.65 M-$2.45 M-$2.95 M-$2.23 M-$3.51 M
EBITDA -$3.56 M-$2.33 M-$2.39 M-$2.91 M-$2.18 M-$2.98 M
Interest Expense -$124.00 K-$149.00 K-$148.00 K-$391.00 K-$304.00 K-$295.00 K
Depreciation $58.00 K$319.00 K$54.00 K$43.00 K$43.00 K$528.00 K
Income Before Tax -$3.71 M-$2.79 M-$3.28 M-$4.17 M-$3.02 M-$3.79 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$3.71 M-$2.79 M-$3.28 M-$4.17 M-$3.02 M-$3.79 M
Net Profit Margin -23156.25%-11176%-12630.77%-19880.95%-13740.91%-14569.23%

AIM ImmunoTech Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $72.00 K$1.00 K$3.00 K$3.00 K$8.00 K$29.00 K
Reserve & Surplus -$430.53 M-$433.33 M-$436.61 M-$440.79 M-$443.81 M-$447.60 M
Non-Current Liabilities $338.00 K$282.00 K$7.53 M$9.34 M$315.00 K$41.00 K
Current Liabilities $9.77 M$10.39 M$4.04 M$6.22 M$6.14 M$4.95 M
Total Liabilities $10.11 M$10.68 M$11.57 M$15.56 M$6.46 M$4.99 M
Fixed Assets $2.37 M$2.26 M$2.12 M$1.73 M$1.72 M$1.77 M
Current Assets $2.58 M$1.02 M$2.58 M$3.29 M$6.21 M$10.43 M
Total Assets $6.25 M$4.13 M$5.49 M$5.78 M$8.59 M$12.73 M

AIM ImmunoTech Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$3.71 M-$2.79 M-$3.28 M-$4.17 M-$3.02 M-$3.79 M
Operating Cash Flow -$2.36 M-$1.53 M-$5.08 M-$1.99 M-$2.72 M-$4.59 M
Investing Cash Flow $898.00 K$754.00 K$296.00 K-$95.00 K-$37.00 K-$112.00 K
Financing Cash Flow $660.00 K$355.00 K$6.65 M$2.72 M$5.59 M$8.79 M
Change in Cash -$803.00 K-$422.00 K$1.87 M$638.00 K$2.83 M$4.08 M

AIM ImmunoTech Inc. Return Calculator

The AIM ImmunoTech Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,029
Invested Amount$10,000
Est. Returns$-8,971
Invest in USA Stock Today

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders, and to treat cancers for which there are currently inadequate or unmet therapies. Its flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) molecule being developed for globally important cancers, viral diseases, and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe Chronic Fatigue Syndrome (CFS).

FAQs

AIM ImmunoTech Inc. (AIM) share price as of September 18, 2026 is $0.21. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the AIM ImmunoTech Inc. (AIM) Share by opening an international trading account with Angel One.
Purchasing AIM ImmunoTech Inc. (AIM) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying AIM ImmunoTech Inc. (AIM) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of AIM ImmunoTech Inc. (AIM) or any other US company shares in Angel One for any dollar amount.
The market capitalization of AIM ImmunoTech Inc. on September 18, 2026, is $8.31 M.
AIM ImmunoTech Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in AIM ImmunoTech Inc. (AIM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91